Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabin strain inactivated poliovirus vaccine (Vero cell) sequential immunization in infants
CTR20190847Phase 3Active
- Sponsor
- Wuhan Institute of Biological Products
- Start
- May 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Wuhan Institute of Biological Products. Started May 2019; status: active.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on CTR20190847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190847.